147 related articles for article (PubMed ID: 21042955)
1. Value of combined detection of AFU and TCH in differential diagnosis between malignant and non-tuberculous benign ascites.
Zhang H; Li F; Wei Q; Zhu YF
Med Oncol; 2011 Dec; 28 Suppl 1():S670-4. PubMed ID: 21042955
[TBL] [Abstract][Full Text] [Related]
2. Serum AFU, GGT and TK1 levels in PHC patients and their correlation with clinicopathology and diagnostic value.
Gong G; Zheng K; Xue S; Hou J; Zhang Q
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):111-116. PubMed ID: 33040823
[TBL] [Abstract][Full Text] [Related]
3. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.
Lu ZY; Cen C; Shao Z; Chen XH; Xu CF; Li YM
World J Gastroenterol; 2016 Feb; 22(5):1884-90. PubMed ID: 26855548
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites.
Sun J; Chang YX; Niu CY
Tumour Biol; 2017 Nov; 39(11):1010428317726840. PubMed ID: 29130388
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites.
Liu F; Kong X; Dou Q; Ye J; Xu D; Shang H; Xu K; Song Y
Ann Hepatol; 2014; 13(3):357-63. PubMed ID: 24756011
[TBL] [Abstract][Full Text] [Related]
6. Ascitic fluid cholesterol in malignant and tubercular ascites.
Sood A; Garg R; Kumar R; Chhina RS; Arora S; Gupta R; Bhatia KL
J Assoc Physicians India; 1995 Nov; 43(11):745-7. PubMed ID: 8773030
[TBL] [Abstract][Full Text] [Related]
7. Diagnosing ascites: value of ascitic fluid total protein, albumin, cholesterol, their ratios, serum-ascites albumin and cholesterol gradient.
Gupta R; Misra SP; Dwivedi M; Misra V; Kumar S; Gupta SC
J Gastroenterol Hepatol; 1995; 10(3):295-9. PubMed ID: 7548806
[TBL] [Abstract][Full Text] [Related]
8. Ascitic fluid cholesterol in differential diagnosis of ascites.
Garg R; Sood A; Arora S; Bhatia KL; Chawla AS; Gupta R; Chawla LS
J Assoc Physicians India; 1993 Oct; 41(10):644-6. PubMed ID: 8294324
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein and insulin-like growth factor-1 in differential diagnosis of ascites.
Abdel-Razik A; Eldars W; Elhelaly R; Elzehery R
J Gastroenterol Hepatol; 2016 Nov; 31(11):1868-1873. PubMed ID: 27010362
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of vascular endothelial growth factor in malignant ascites.
Zhan N; Dong WG; Wang J
Tumour Biol; 2016 Mar; 37(3):3719-25. PubMed ID: 26462841
[TBL] [Abstract][Full Text] [Related]
11. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Accuracy of Tumor Markers CYFRA21-1 and CA125 in the Differential Diagnosis of Ascites.
Trapé J; Gurt G; Franquesa J; Montesinos J; Arnau A; Sala M; Sant F; Casado E; Ordeig JM; Bergos C; Vida F; Sort P; Isava Á; González M; Molina R
Anticancer Res; 2015 Oct; 35(10):5655-60. PubMed ID: 26408739
[TBL] [Abstract][Full Text] [Related]
13. Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma.
Zhu J; Jiang F; Ni HB; Xiao MB; Chen BY; Ni WK; Lu CH; Ni RZ
Exp Ther Med; 2013 Jan; 5(1):89-94. PubMed ID: 23251247
[TBL] [Abstract][Full Text] [Related]
14. Alpha-L-fucosidase as a tumour marker of hepatocellular carcinoma.
Fawzy Montaser M; Amin Sakr M; Omar Khalifa M
Arab J Gastroenterol; 2012 Mar; 13(1):9-13. PubMed ID: 22560818
[TBL] [Abstract][Full Text] [Related]
15. The Applicability of ADA, AFU, and LAC in the Early Diagnosis and Disease Risk Assessment of Hepatitis B-Associated Liver Cirrhosis and Hepatocellular Carcinoma.
Zhang W; Chen Z; Xue C; Zhang Y; Wu L; Zhu J; Xuan S; Tian J; Pang Z
Front Med (Lausanne); 2021; 8():740029. PubMed ID: 34557505
[No Abstract] [Full Text] [Related]
16. A Novel Combination of C-Reactive Protein and Vascular Endothelial Growth Factor in Differential Diagnosis of Ascites.
Abdel-Razik A; Mousa N; Elalfy H; Sheta TF; Awad M; Abdelsalam M; Elhelaly R; Elzehery R; Gouda NS; Eldars W
J Gastrointest Cancer; 2017 Mar; 48(1):50-57. PubMed ID: 27614744
[TBL] [Abstract][Full Text] [Related]
17. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites.
Zhu FL; Ling AS; Wei Q; Ma J; Lu G
Asian Pac J Cancer Prev; 2015; 16(2):719-22. PubMed ID: 25684514
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of malignant versus tuberculous ascites using tumor markers and globulin ratios in serum and ascites: A Fisher discriminant model.
Yu T; Shu L; Chen Y; Zhu Y; Lu N; Lai Y; Huang T; Shu X
Arab J Gastroenterol; 2021 Jun; 22(2):93-98. PubMed ID: 34090828
[TBL] [Abstract][Full Text] [Related]
19. Study of biochemical parameters of ascitic fluid in exudative ascites with special reference to tuberculous peritonitis.
Bandyopadhyay R; Bandyopadhyay SK; Ghosal J; Kumar U; Dutta A
J Indian Med Assoc; 2006 Apr; 104(4):174, 176-7, 185. PubMed ID: 16910322
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
Rana SV; Babu SG; Kocchar R
Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
